CyberKnife for Early Stage Lung Cancer Continues to be Superior to Surgery

Two years after this study was published, survival rates for lung cancer patients treated with the CyberKnife continue to climb. Lung cancer patients treated with the CyberKnife are simply outliving those who had surgery. This is fantastic news! Read more about the original study here:

Treatment for lung cancer with radiation therapy is proven to be superior to surgery. In a landmark study published in the Lancet Oncology June 2015 16(6) 630-637, cancer specialists reported that early stage lung cancer patients treated with stereotactic ablative body radiotherapy (SABR), like that delivered by CyberKnife, had a 3 year overall survival of 95%. Surprisingly, early stage lung cancer patients faired much worse with open surgery (lobectomy) with a 3 year overall survival of only 79%.

CyberKnife treatment stands in stark contrast to surgery. CyberKnife is a highly specialized form of radiation therapy done on an outpatient basis in 3-5 visits, with no pain and no cutting. A lobectomy on the other hand is a major operation where surgeons open your chest and remove an entire lobe of your lung. Requiring a prolonged hospital stay with all the risks of surgery on the chest.

Dr. Joe Y. Chang, a professor of radiation oncology at the world famous M.D. Anderson Cancer Center told Medscape, “For the first time, we can say that the 2 therapies are at least equally effective, and the stereotactic ablative radiotherapy (CyberKnife) appears to be better tolerated and might led to better survival outcomes for these patients.”

WHY IS THIS IMPORTANT FOR PATIENTS AND PHYSICIANS TO KNOW?

I believe this study is telling us that CyberKnife is a good solution as compared to open surgery. And a solution that does not require a major operation. No incisions, no pain, and no prolonged hospital stays with a difficult recovery. CyberKnife is painless and quick. You simply lay on a table and relax. No need to even get undressed.

WHAT IS THE CYBERKNIFE ADVANTAGE?

There are other stereotactic systems found at area hospitals. However, the CyberKnife is the ONLY stereotactic radiation device that actually breathes with you. There is no breath holding. This system has real time x-ray imaging that tracks your movement ensuring that it only targets the tumor and spares healthy tissue. This results in fewer long term side effects and offers immediate results.

First Dayton is the ONLY cancer center in southwest Ohio with the CyberKnife system for treating lung cancers. Discover if CyberKnife is the right choice to treat your lung cancer by calling me today, Dr. Ed Hughes at 855-DAYTON1.

Learn more about CyberKnife Treatment for Lung Cancer here.

Leave a Reply